Larotrectinib
Larotrectinib is an active ingredient in 7 FDA-listed drug products sold under 1 name.
Drugs containing Larotrectinib
- Vitrakvi 7
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 50419-392 | Vitrakvi Solution, Concentrate | 20 mg/mL | Bayer HealthCare Pharmaceuticals Inc. |
| 50419-390 | Vitrakvi Capsule | 25 mg/1 | Bayer HealthCare Pharmaceuticals Inc. |
| 50419-391 | Vitrakvi Capsule | 100 mg/1 | Bayer HealthCare Pharmaceuticals Inc. |
| 50419-393 | Vitrakvi Solution, Concentrate | 20 mg/mL | Bayer HealthCare Pharmaceuticals Inc. |
| 71777-392 | Vitrakvi Solution | 20 mg/mL | Loxo Oncology, Inc. |
| 71777-390 | Vitrakvi Capsule | 25 mg/1 | Loxo Oncology, Inc. |
| 71777-391 | Vitrakvi Capsule | 100 mg/1 | Loxo Oncology, Inc. |